Literature DB >> 24034179

Nuclear Factor-kappaB-Mediated Endothelin Receptor Up-Regulation Increases Renal Artery Contractility in Rats.

Yan-Hua Xie1, Si-Wang Wang1, Yaping Zhang2, Lars Edvinsson3, Cang-Bao Xu2,3.   

Abstract

Increased renal artery contractility leads to renal vasospasm and ischaemia as well as kidney damage. This study was designed to examine the hypothesis that organ culture of renal arteries induces transcriptional up-regulation of endothelin type A (ETA ) and type B2 (ETB2 ) receptors in the smooth muscle cells via activation of nuclear factor-kappaB (NF-κB) and subsequently increases renal artery contractility. Rat renal artery segments were organ-cultured for 6 or 24 hr to increase endothelin receptor-mediated contraction. To dissect molecular mechanisms involved in this process, inhibitors for NF-κB signalling pathway (MG-132 and BMS345541), transcription (actinomycin D) and translation (cycloheximide) were used during organ culture. Endothelin receptors were studied using a sensitive myograph (functional contractility), real-time PCR (mRNA analysis) and immunohistochemistry (protein localization). Compared with fresh segments, contractile responses to endothelin-1 (non-selective endothelin receptor agonist) and sarafotoxin 6c (selective ETB receptor agonist) were significantly increased in the segments after 24 hr of organ culture; ETB2 receptor-mediated maximal contraction increased from 2.7 ± 0.5 to 135.3 ± 5.1 (p < 0.001), and potency (pEC50 ) of ETA receptor agonist increased from 8.20 ± 0.04 to 8.72 ± 0.07 (p < 0.001). This was in parallel with increased corresponding mRNA and protein expression for ETA and ETB2 receptors. BMS345541, MG-132, actinomycin D or cyclohexamide, respectively, suppressed the up-regulation of ETA and ETB2 receptors. Immunostaining performed with specific antibody showed that IκB was phosphorylated during organ culture. In conclusion, activation of NF-κB mediates up-regulation of ETA and ETB2 receptors and subsequently increases renal artery contractility, which may contribute to renal vasospasm and ischaemia as well as kidney damage.
© 2013 Nordic Pharmacological Society. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24034179     DOI: 10.1111/bcpt.12123

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  3 in total

Review 1.  Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.

Authors:  Yan-Yang Wang; Yin-Xue Yang; Hong Zhe; Zhi-Xu He; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-10-23       Impact factor: 4.162

2.  Downregulation of Thromboxane A2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery.

Authors:  Yaping Zhang; Man Mi; Yan-Hua Xie; Si-Wang Wang; Lars Edvinsson; Cang-Bao Xu
Journal:  Adv Pharmacol Sci       Date:  2017-07-09

3.  An Autopsy Case of Nonocclusive Mesenteric Ischemia with Bilateral Renal Artery Vasoconstriction.

Authors:  Ibuki Kurihara; Keiji Hirai; Susumu Ookawara; Akira Tanaka; Tsuneaki Kenzaka; Hitoshi Sugawara
Journal:  Am J Case Rep       Date:  2022-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.